Gaza Aid Foundation Says Eight Workers Killed by Hamas
Eight Palestinian aid workers were killed and several injured when a bus they were traveling in was attacked by Hamas militants in central Gaza, a foundation backed by the US and Israel said Thursday.
The vehicle was en route to an aid-distribution center west of the city of Khan Younis when it came under fire at 10 p.m. local time, according to the Gaza Humanitarian Foundation. It expressed concern that Hamas had taken some of the more than two dozen passengers hostage. Hamas has yet to respond to the accusations.
'We condemn this heinous and deliberate attack in the strongest possible terms,' the foundation said in a statement. 'For days, Hamas has openly threatened our team, our aid workers, and the civilians who receive aid from us.'
GHF's interim executive director, John Acree, said the group will continue food deliveries despite the attack.
The GHF, a Switzerland-based nonprofit, began operating in Gaza in late May following a 13-week-long Israeli blockade of the territory. It has been dispensing aid from centers in central and southern Gaza that have been inundated with people. Israeli forces said they had in recent weeks fired at Palestinians headed toward one center, citing a security threat.
The organization said it distributed over 2.6 million meals on Thursday through three sites in central and southern Gaza Strip, but Palestinians have complained that the random distribution process lacks beneficiary data that would ensure the food is handed out fairly. The UN and other traditional relief groups operating in Gaza have refused to work the GHF.
The Hamas-run Health Ministry said that 57 people were killed in areas adjacent to the distribution sites on Wednesday, bringing the total who had died in such incidents to 224.
Hamas attacked southern Israel on Oct. 7, 2023, killing 1,200 people and sparking a war in Gaza that has dragged on for almost 20 months. More than 55,000 Palestinians have been killed, according to the Hamas-run health ministry, while large parts of the territory have been reduced to rubble.
Many of the more than the 2 million Palestinians living in Gaza were dependent on aid before the fighting erupted and their plight has grown increasingly desperate. Israel has sidelined United Nations agencies from distribution, accusing them of being too close to Hamas, which the US has designated a terrorist group.
The GHF has handed out more than 10 million meals in Gaza over recent weeks, the military said in a post on social media platform X.
The foundation said it would carry on issuing aid despite the latest attack on its workers.
This article was generated from an automated news agency feed without modifications to text.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
5 hours ago
- The Hindu
Doctors at Kallakurichi Government Medical College and Hospital perform cochlear implant surgery on six children in a year
S. Anand Babu, 37, an employee of Aavin, from Mathur near Kallakurichi is happy to see his five-year-old son Kovegan call him 'Appa'. Earlier, the child did not respond when his name was called and was unresponsive to everyday sounds. Born with bilateral profound sensorineural hearing loss, the child could not speak till the age of four. But all that changed when he underwent free cochlear implant surgery under the Chief Minister's Comprehensive Health Insurance Scheme at the Kallakurichi Government Medical College and Hospital (KGMCH) in 2024. 'When he was two-and-a-half years old, we realised that he was not responding to sounds. We took him to the Kallakurichi Government Medical College and Hospital where doctors performed a surgery on June 12, 2024. He is now slowly picking up words', says Mr. Anand Babu. According to a doctor, the child, identified through newborn hearing screening, underwent thorough pre-operative evaluation, including BERA, MRI, and CT scans. The team led by Chennai-based expert otorhinolaryngologist Mohan Kameswaran performed the surgery with assistance from the local ENT team, and successfully implanted a multi-channel digital cochlear device. The device was switched on after four weeks and regular auditory-verbal therapy was initiated. There was significant improvement in the child's auditory comprehension and he progressed from Level 0 (No awareness) to Level 5 (understands common phrases without lip reading). Kovegan is among six children aged below five years suffering from profound hearing loss from Kallakurichi district, who have undergone surgery for cochlear implant. The first surgery was performed on Kovegan. Picking up since then, the ENT team at KGMCH has completed six cochlear implants in the last one year. Another surgery is scheduled for June 18. According to Professor Sowndararajan, Head, Department of ENT, KGMCH, 'The implants, which cost more than ₹4 lakh, are funded by the Tamil Nadu Chief Minister's Comprehensive Health Insurance Scheme. Patients receive the entire surgery and post-operative treatment free of cost. At KGMCH, free screening is done for all newborns.'
&w=3840&q=100)
Business Standard
6 hours ago
- Business Standard
Serum Institute signs MoU with DNDi to develop dengue treatment candidate
Serum Institute of India (SII) on Friday signed a memorandum of understanding (MoU) with medical research organisation Drugs for Neglected Diseases initiative (DNDi) to accelerate clinical development of a monoclonal antibody treatment for dengue that will be affordable and accessible in low- and middle-income countries (LMICs). As part of the collaboration, both SII and DNDi will develop a work plan to implement research and development, Phase 3 clinical trials, and access activities, along with a joint strategy to raise the necessary funds and resources. SII stated that it has already conducted pre-clinical studies and Phase 1 and 2 clinical trials that show the candidate (formerly VIS513) is safe and effective. It is currently leading the Phase 3 clinical trial in India for licensure. SII and DNDi will now work together to conduct additional Phase 3 trials in other dengue-endemic countries as well, such as Brazil. The Pune-based company added that a joint project team will be formed to advance clinical trials, with the goal of registering and deploying the dengue monoclonal antibody in India and other countries, provided the studies confirm its safety and efficacy. Commenting on the partnership, Prasad Kulkarni, executive director at SII, said that the collaboration with DNDi will be instrumental in advancing clinical development of a dengue monoclonal antibody in Brazil and potentially other endemic countries in Southeast Asia, with a focus on making treatment affordable and accessible. DNDi will act as the lead partner for these clinical trials, including trial leadership, sponsorship, and implementation in Brazil and potentially other endemic countries in Southeast Asia. 'Both participants will also lead strategic engagement efforts with the Dengue Alliance, relevant industry stakeholders, and policymakers in LMICs,' they added. Kavita Singh, Asia Continental Lead and Director – South Asia at DNDi, said that India reports tens of thousands of dengue cases every year, with outbreaks occurring every two to three years in different states. 'Addressing the growing threat demands a multi-pronged approach, including strengthened vector control, surveillance, community awareness and the development of effective treatments and diagnostics,' she added.
India Today
6 hours ago
- India Today
Indian-American physician gets 10-year jail term for healthcare fraud
A 52-year-old Indian-American physician from Chicago, Mona Ghosh, was sentenced to a 10-year jail term for medical fraud. She submitted reimbursement claims for services and procedures that were either not provided or not medically necessary. Prosecutors said the fraud endangered patients' health and 2018 and 2022, she submitted fraudulent claims to federal programmes such as Medicaid and Tricare, as well as to private insurers, and also directed her employees to do the also said some procedures were performed without patient consent, according to a statement issued by the US Attorney's Office, Northern District of Illinois. Mona Ghosh owned and operated Progressive Women's Healthcare, which specialises in obstetrics and gynaecology fraudulent claims included endometrial ablations and biopsies, ultrasounds, vaccinations, laboratory blood tests, and tests for sexually transmitted used wrong billing codes, a standardised system used to identify and report the services and procedures provided by healthcare professionals in the US, to make the visits seem more serious than they really were, so she could get more money than she was supposed to."Ghosh also fraudulently overstated the length and complexity of in-office and telemedicine visits and submitted claims using billing codes for which the visits did not qualify in order to seek higher reimbursement rates. Ghosh prepared false patient medical records to support the fraudulent reimbursement claims", the statement who belongs to Inverness in Illinois, on June 27 last year pleaded guilty to two counts of healthcare fraud. On June 9, US District Judge Franklin U Valderrama imposed the ten-year prison sentence and ordered Ghosh to pay approximately $1.5 million (approximately Rs 12.5 crore) in GHOSH'S FRAUD ENDANGERED PATIENTS' HEALTH: US ATTORNEY"When physicians submit fraudulent claims to federal health care programs, they divert taxpayer-funded resources away from those who truly need them," said US Attorney Boutros."Dr Ghosh's fraud scheme was particularly egregious because she endangered the health of her patients by performing unnecessary medical procedures, including procedures that severely limited some patients' ability to have children in the future (sic)," Boutros attorney also applauded the victims' strength to come forward and confront this defendant."Dr Ghosh spent years traumatising patients, lying to insurers, and stealing taxpayer money to feed her greed (sic)," said FBI SAC this month, a US-based, Indian-origin pharma tycoon was arrested at Los Angeles International Airport over his alleged involvement in a $149-million healthcare fraud. Tonmoy Sharma, 61, originally from Guwahati, Assam, is the founder and former CEO of Sovereign Health Group, a company that provides addiction treatment services.
